Sort
130,381 grants matching “hiv”
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
$970,913Sidney Waldo Whiteheart · University Of Kentucky · R35 · FY2020 · HL
BE FAITHFUL, BE TREATED, BE UNION PROJECT- TO EXPAND ACCESS TO HIV-RELATED SERVIC
$970,905Marc Bayard · American Ctr For Intl Labor Solidarity · U2G · FY2009 · PS
Delaware Valley Node of the Clinical Trials Network
$970,902George E Woody · University Of Pennsylvania · U10 · FY2010 · DA
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$970,881Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Integrating Sex &Drug Related HIV Risk &Transmission
$970,720Yale University · U01 · FY2005 · DA
TISSUE-BASED SMALL ANIMAL MODEL FOR HIV DRUG DISCOVERY
$970,687J. David Gladstone Institutes · N01 · FY2000 · AI
Identification of key players mediating internalization of Trichomonas vaginalis extracellular vesicles by host cells and parasite adherence and survival in vivo
$970,686Patricia Jean Johnson · University Of California Los Angeles · R01 · FY2024 · AI
Cognitive Function, Alzheimer's Disease and Related Disorders in the HAALSI Cohort
$970,663Lisa F Berkman · Harvard School Of Public Health · R01 · FY2020 · AG
Durable HIV Vaccine Targeting Mucosal Epithelium
$970,600Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2024 · AI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.
$970,487Matthew A. Spinelli · University Of California, San Francisco · UG3 · FY2024 · DA
Developmental Core (Core B)
$970,485John Koethe · Vanderbilt University Medical Center · P30 · FY2023 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$970,435Katharine June Bar · University Of Pennsylvania · R01 · FY2022 · MH
Clinical Trials Network: Greater New York Node
$970,323Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2011 · DA
Texas Center for Minority Health, Education, Research and Outreach
$970,271Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2021 · MD
Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.
$970,180Scott W Wong · Oregon Health & Science University · R01 · FY2019 · CA
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
$970,160Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2022 · AI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis
$970,147Aaron Richard McCabe · Minnetronix, Inc. · R42 · FY2019 · AI
Genomic and environmental risk factors for cardiometabolic disease in Africans
$970,000Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2013 · HG
Center for Fetal Gene Transfer for HLB Diseases
$969,939University Of California Davis · U01 · FY2004 · HL
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
$969,771Zhi-Ming Zheng · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
NATURAL HISTORY OF ANAL NEOPLASIA IN HIV INFECTED MEN
$969,726University Of California San Francisco · R01 · FY2000 · CA
Monoclonal antibody-based intervention against SIV in nonhuman primates
$969,528Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Functional And Phenotypic Characterization Of T Cells In Man
$969,528Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Northern Pacific Global Health Leadership, Education, and Development for Early-career Researchers (NPGH LEADERs)
$969,500Joseph Raymond Zunt · University Of Washington · D43 · FY2025 · TW
Genetics and Progression of Early-onset Substance Dependence and HIV Risk
$969,350Christian J Hopfer · University Of Colorado Denver · R01 · FY2018 · DA